Cytokinetics Inc. (NASDAQ: CYTK) Announces Three Year Partnership With American Heart Association Bay Area

Cytokinetics Inc. (NASDAQ: CYTK) has announced a three-year collaboration with American Heart Association (AHA) Bay Area to accelerate awareness and education on heart disease. In addition, Cytokinetics will offer to fund and support various initiatives headed by AHA Bay Area as part of the partnership.

Cytokinetics to support Research Roundtable 

This year Cytokinetics will support the Research Roundtable, a fundraising event for the life sciences sector. Cytokinetics will also sponsor several Bay Area Heart Walks by creating a strengthened VIP neighborhood for patients and families, offering additional capacity for friends, families, coworkers, and neighbors to show their dedication to their health and respect loved ones who have suffered from heart disease or stroke. Furthermore, Cytokinetics will finance the creation of three new patient films in the AHA series, “Conversations from the Heart,” to be broadcast online and through social media throughout the year.

The company can better fulfill its obligation of assisting folks in the community by collaborating with the AHA Bay Area, and there’s no better moment to announce the relationship than during Heart Month.

CEO Robert Blum stated, “Heart disease is the leading cause of death in the U.S., and for many diseases such as heart failure, the prevalence is only increasing. As we remain dedicated to our mission to address unmet needs in diseases like heart failure and hypertrophic cardiomyopathy, it remains a top priority to elevate attention of heart disease, and we look forward to continuing to work together with the AHA Bay Area to advance their goals and initiatives.”

Cytokinetics’ support to allows AHA to expand its reach 

AHA Bay Area SVP and Executive Director Laura Steinfedt stated, “We are grateful to be expanding our efforts with Cytokinetics through this collaborative effort. Heart disease affects so many people across the country, and Cytokinetics’ support allows us to expand our outreach to patients and caregivers impacted by heart disease in our local communities and ensure equitable access to resources for all.

Heart disease remains the major cause of death in the US, accounting for 659,000 deaths every year, or around one out of every four deaths.